Download PDF
1 / Pages

Other users also viewed these articles

Perception of the impact of intravenous biological treatment on the work and professional environment in patients with inflammatory bowel disease Carlos González-Muñoza; Cristina Gely; Jordi Gordillo; Margalida Calafat; Federico Bertoletti; Fiorella Cañete; Míriam Mañosa; Alberto López-Faba; Paola Torres; Eugeni Domènech; Esther Garcia-Planella;
Gastroenterol Hepatol. 2024;47:
Changes in the intensified regimen of infliximab in patients with inflammatory bowel disease in sustained remission: Reflections on a series of cases Laura Gutiérrez-Rios; Eva Vayreda; Margalida Calafat; Fiorella Cañete; Eugeni Domènech; Míriam Mañosa;
Gastroenterol Hepatol. 2024;47:867-8
Incidence of herpes zoster in patients with inflammatory bowel disease Anna Calm; Margalida Calafat; Carlos González-Muñoza; Fiorella Cañete; Cristina Roig; Míriam Mañosa; Esther Garcia-Planella; Eugeni Domènech;
Gastroenterol Hepatol. 2024;47:598-604